SEATTLE–(BUSINESS WIRE)– #SpotVisionScreener–The growth of the North America spot vision screener market is attributed to the increasing demand for eye screening tests in the U.S.
Author: Business Wire
Horizon Therapeutics plc Announces TEPEZZA® (teprotumumab-trbw) Selected as a Winner of the R&D 100 Award
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced that TEPEZZA® (teprotumumab-trbw) was selected as a 2020 R&D World R&D 100 Award recipient in the Process/Prototyping category. TEPEZZA is the first and only medic…
Eyevensys a obtenu de la FDA la désignation de médicament orphelin pour EYS611 pour le traitement de la rétinite pigmentaire
PARIS et CAMBRIDGE, Massachusetts–(BUSINESS WIRE)–Eyevensys, une société de biotechnologie privée au stade clinique développant des thérapies géniques non virales pour le traitement des maladies ophtalmiques, a annoncé aujourd’hui que l’Agence améric…
Eyevensys Receives FDA Orphan Drug Designation for EYS611 for Treatment of Retinitis Pigmentosa
PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)– #genetherapy–Eyevensys receives FDA Orphan Drug Designation for EYS611 for treatment of retinitis pigmentosa.
Eyenovia to Present Clinical Study Updates at the American Academy of Optometry Annual Meeting
NEW YORK–(BUSINESS WIRE)– #AAOPT–Drs. Siddarth Rathi, April Jasper to present latest analyses and updates from Eyenovia’s clinical studies at the American Academy of Optometry 2020
Diamond Pharma Services Supports GenSight Biologics in Submitting Its First Marketing Authorisation Application, for Ocular Gene Therapy LUMEVOQ
HARLOW, England–(BUSINESS WIRE)–Diamond Pharma Services (“Diamond”), a leading technical services and regulatory affairs consulting group, has announced that it provided EU regulatory, pharmacovigilance, quality and compliance support to GenSight Bio…
SCHOTT AG and Credence MedSystems Form a Strategic Collaboration Agreement to Make Syringe Injections Safer for the Benefit of Patients Worldwide
MAINZ, Germany & MENLO PARK, Calif.–(BUSINESS WIRE)–Credence MedSystems and SCHOTT AG have formed a collaboration for the application of Credence Companion® technology with SCHOTT’s pre-fillable syriQ® glass and SCHOTT TOPPAC® polymer syringe systems…
LENSAR, Inc. Begins Trading on NASDAQ
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on femtosecond laser surgical solutions for the treatment of cataracts, today announced the completion of its spin-off …
IVERIC bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK–(BUSINESS WIRE)–IVERIC bio reported that it granted a newly hired employee a non-statutory stock option to purchase 14,000 shares of the Company’s common stock.
Eyewear Market to Reach USD 57.69 bn by 2024, Bausch Health Companies Inc and Carl Zeiss AG Emerge as Key Contributors to Growth | Technavio
LONDON–(BUSINESS WIRE)– #EyewearMarket–The Global Eyewear Market will grow by USD 57.69 bn during 2020-2024
Amerigroup Introduces Medicare Advantage Plan to Help Iowans Eligible for Medicare and Medicaid Lead Healthier Lives
DES MOINES, Iowa–(BUSINESS WIRE)–Amerigroup is introducing a 2021 Medicare Advantage plan for Iowans eligible for Medicare and Medicaid to help them improve their health and wellbeing. This plan will be available in 21 Iowa counties and will offer me…
Centricity Vision Appoints Jim Mazzo to its Board of Directors
CARLSBAD, Calif.–(BUSINESS WIRE)–Centricity Vision, Inc., a global ophthalmic technology company dedicated to delivering solutions that help surgeons achieve surgical and clinical excellence, today announced that Jim Mazzo has been appointed to the c…
Omeros Provides Update on Separate Payment for OMIDRIA® in the ASCs
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) today provided an update on the status of reimbursement for its cataract surgery drug OMIDRIA® (phenylephrine and ketorolac intraocular solution) 1%/0.3%. The two-year extension of pass-throug…
EyeGuide Adds Six Sports Medicine, Neuroscience Experts to Scientific Advisory Board
PHILADELPHIA–(BUSINESS WIRE)–EyeGuide Inc., a health technology and bioinformatics company revolutionizing the way brain health is monitored, has announced the expansion of its scientific advisory board with the additions of Dr. Anne Naclerio, Dr. Dh…
UnitedHealthcare's 2021 Medicare Plans Bring Unique Solutions for Unique Times
MINNETONKA, Minn.–(BUSINESS WIRE)–UnitedHealthcare® today introduced its 2021 Medicare Advantage and prescription drug plans, showcasing affordable coverage, exclusive benefits, expanded plan access and a simplified member experience that connects pe…
Congress passes, President Trump signs HR 4920 to preserve jobs, rehabilitative services for individuals who are blind or visually impaired
INDIANAPOLIS–(BUSINESS WIRE)– #AbilityOne–When President Trump signed House Resolution 4920 last month, the bipartisan bill received little attention. However, it will have an enormous impact on Americans who are blind or visually impaired and their…
Europe Age-Related Macular Degeneration Market and Competitive Landscape Report 2020 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Europe Age-Related Macular Degeneration Market and Competitive Landscape – 2020” report has been added to ResearchAndMarkets.com’s offering. Europe Age-Related Macular Degeneration Market and Competitive Landscape – 2020, …
Europe Diabetic Retinopathy Market and Competitive Landscape Report 2020 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Europe Diabetic Retinopathy Market and Competitive Landscape – 2020” report has been added to ResearchAndMarkets.com’s offering. Europe Diabetic Retinopathy Market and Competitive Landscape – 2020, provides comprehensive i…
EHE Health Warns That Gap in Preventive Care During COVID-19 Is the Next Great Health Crisis
NEW YORK–(BUSINESS WIRE)– #ehehealth–EHE Health, a leading national preventive and primary healthcare organization, today warned that the sharp decline in preventive care visits and health screenings during COVID-19 will lead to a surge in cardiovas…
SENTA Expands Presence to 50 Providers and 23 Clinical Locations in Metro Atlanta Through Affiliation With Atlanta Allergy & Asthma
ATLANTA–(BUSINESS WIRE)–Southern Ear Nose Throat & Allergy (“SENTA”) Partners is pleased to announce that it has completed an affiliation with Atlanta Allergy & Asthma (“Atlanta Allergy”). SENTA is an ENT and allergy management services organ…